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1. Introduction 
Glutamic acid 270 and tyrosine 248 have been 
implicated in the catalytic mechanism of carboxypep- 
tidase A. The y-carboxylate of glutamic acid 270 is 
believed to function as nucleophile in the hydrolysis 
of peptide and ester substrates [l] . Modification of 
glutamic acid 270 either by Woodward reagent K 
[2,3] or by the affinity label, N-bromoacetyl-N- 
methyl-Lphenylalanine (BrAcN(Me)Phe) [4,5] 
produces loss of enzymatic activity. The reaction of 
carboxypeptidase A with BrAcN(Me)Phe obeys 
saturation kinetics allowing separate estimation of 
the contributions of binding and reactivity (i.e. 
nucleophilicity and orientation) to the observed rate 
of inactivation. 
Modification of tyrosine 248 by several reagents, 
including N-acetylimidazole [7] produces enzyme 
derivatives with greatly reduced peptidase activity. 
Lipscomb has proposed that the phenolic hydroxyl 
of tyrosine 248 serves as proton donor in the hydroly- 
sis of peptide substrates based both on the effect of 
chemical modification of tyrosine 248 and upon the 
location of this residue relative to the susceptible 
peptide bond as determined by X-ray crystallographic 
analysis [ 11. Alternatively, tyrosine 248 could func- 
tion by orienting the substrate for nucleophilic attack 
by glutamic acid 270 rather than by direct participa- 
tion in catalysis. 
The affinity labeling of the nitro and acetyl deriva- 
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tives of carboxypeptidase A by BrAcN(Me)Phe was 
undertaken to further elucidate the role of tyrosine 
248. 
2. Experimental 
2.1. Materials 
Carboxypeptidase GFeU was prepared from com- 
mercial, crystalline enzyme (Worthington Biochemical 
Corp.) by ion exchange chromatography in the pres- 
ence of 3-phenylpropionate [ 81. 
Nitro-carboxypeptidase was prepared by treating 
the enzyme with tetranitromethane (Aldrich Chemical 
Co.) in 1 M NaCI-0.05 M Tris-HCl, pH 8.0 for 
45 min at 25°C [6]. Enzyme derivatives containing 
1.4 and 3.6 residues of 3-NO2 -tyrosine per molecule 
were prepared by employing eight-fold and sixty-fold 
molar excesses of reagent, respectively. Nitro-carboxy- 
peptidases qeu was separated from a small amount 
of cross-linked species and from excess reagents by 
chromatography on a column of Sephadex G-100 
(Pharmacia). 
Acetyl-carboxypeptidase llFeU was prepared 
using a sixty-four fold molar excess of N-acetylimida- 
zole as described previously [7] . De-acetylation of the 
modified tyrosine residues was effected by incubating 
acetyl-carboxypeptidase with 1.18 M hydroxylamine- 
HCl at pH 7.5 [7]. 
N-Bromoacetyl-N-methyl-Lphenylalanine was 
prepared as described previously [4]. 
2.2. Methods 
Protein concentrations of stock solutions of native 
acetyl- and nitro-carboxypeptidase Ateu were deter- 
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mined by amino acid analysis after acid hydrolysis 
of appropriate aliquots. Amino acid analysis was also 
employed to assess the extent of modification of ty- 
rosine by tetranitromethane. 
Peptidase activity of carboxypeptidase and its 
derivatives was determined at pH 7.5 and 25°C using 
1.18 mM carbobenzoxyglycyl-Cphenylalanine (Fox 
Chemical Co.) as substrate [9]. Esterase activity 
toward 10 mM hippuryl-D-L-/I-phenyllactic acid 
(Cycle Chemical Corp.) was determined at 25’C by 
pH titration using a pH-stat and toward 1 mM substrate 
by monitoring the increase in absorbance at 254 mM 
[lOI. 
The rates of inactivation of carboxypeptidase and 
its derivatives by various concentrations of BrAcN- 
(Me)Phe were determined in 1 M NaCl-0.01 M Tris- 
HCl, pH 7.5 at 25’C [4]. The half-times of inactiva- 
tion (tl j2) were determined from semilogarithmic 
plots of remaining esterase activity (determined with 
1 mM BzGlyOPhe) against time. The constants 
K inact’ the concentration of BrAcN(Me)Phe producing 
half-maximal rate of inactivation, and T, the half- 
time of inactivation extrapolated to saturating levels 
of the reagent, were calculated by plotting tr j2 
against the reciprocal reagent concentration according 
toeq. 1 [4,11]. 
K. T 
t112 = [BrActyMe)Phe] 
+T (1) 
3. Results 
3.1. Nitwcarboxypeptidase A 
Treatment of carboxypeptidase with low concen- 
trations of tetranitromethane resulted in preferential 
modification of a catalytically functional tyrosine 
residue [6] . In analogy with the nitration of the 
homologous enzyme, carboxypeptidase B [ 121, this 
residue has been tentatively identified as tyrosine 
248. Enzyme derivatives containing on the average 
1.4 and 3.6 3-NO2 -tyrosine residues per molecule 
exhibited decreased peptidase activity toward Z-Gly- 
Phe (10% of original) and slightly increased esterase 
activity (120% of original) using 10 mM Bz-Gly- 
OPhe as substrate. These results are in agreement with 
previous observations [6] . 
Inactivation of nitro-carboxypeptidase by BrAcN- 
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Fig. 1. Half-time of inactivation of nitro-carboxypeptidase A 
as a function of the reciprocal concentration of BrAcN(Me) 
Phe. Enzyme derivatives contained on the average 1.4 (o----o) 
and 3.6 (o---o) residues 3-NO,-tyrosine per molecule. 
(Me)Phe followed first order kinetics with respect to 
remaining active enzyme suggesting that the various 
forms of nitro-carboxypeptidase B present in each 
preparation of modified enzyme all react at approxi- 
mately the same rate. 
The effect of concentration of BrAcN(Me)Phe on 
the rates of inactivation of the nitro-carboxypeptidase 
A derivatives is presented in fig. 1. Nitration of 
tyrosine-248 appears to weaken slightly reversible 
binding of BrAcN(Me)Phe to enzyme as suggested by 
increased values of Kinact for the nitro-carboxypepi- 
dases (table l), and to decrease the apparent first order 
rate constant (In2/T) of the reaction of BrAcN(Me)- 
F%e with glutamic acid 270 in the enzyme-inhibitor 
complex (table 1). These effects are slightly more 
pronounced with the enzyme derivative containing an 
average of 3.6 residues of 3-NO2 tyrosine per molecule. 
3.2. Acetyl-carboxypeptidase A 
Acetylation of carboxypeptidase A with N-acetyl- 
imidazole generates an enzyme derivative of decreased 
peptidase activity toward Z-Gly-Phe (20% of origi- 
nal) and substantially increased (300% of original) 
esterase activity using 10 mM Bz-Gly-OPhe as sub- 
strate, in reasonable agreement with previous reports 
[7,9]. Under the conditions employed in these ex- 
periments, an average of four tyrosine residues 
(presumably including tyrosine 248) are acetylated 
with little modification of other types of residues. 
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Table I 
Kinetic parameters of the reaction of native and modified 
carboxypeptidase A with BrAcN(Me)Phe* 
Enzyme T (Mm) Kinact 
(mM) 
Native 3.6 + 0.4 4.8 
Acetylated 1.7 f 0.1 10.2 
Acetylated, treated with NH, OH 3.4 * 0.5 4.9 
Nitrated (3.6 residues of 3-NO, - 
Tyr/molecule) 11.7 i 1.7 13.0 
Nitrated (1.4 residues of 3-NO, - 
Tyr/molecule) 9.3 + 0.8 9.3 
* T = half-time of inactivation, extrapolated to saturating 
levels of BrAcN(Me)Phe. 
Kinact = concentration of BrAcN(Me)Phe producting half- 
maximal rate of inactivation. 
Values for T and Kinact were determined by least-squares 
analysis of plots of fL/2 against BrAcN(Me)Phe- I. T and 
Kinact for acetylcarboxypeptidase were estimated at con- 
centrations of BrAcN(Me)Phe (2.5-6.6 mM) at which excess 
inhibitor protection was not observed. For experimental 
details see text. 
The effect of concentration of BrAcN(Me)Phe 
on the rate of inactivation of acetyl-carboxypeptidase 
A is presented in fig. 2. It is apparent that acetylation, 
like nitration, results in weaker reversible binding of 
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Fig. 2. Half-time of inactivation of (1) carboxypeptidase A 
(o*), (2) acetyl-carboxypeptidase A (AA), and (3) 
the acetylderivative of carboxypeptidase A after hydroxyla- 
mine treatment (o- o) as a function of the reciprocal of 
BrAcN(Me)Phe concentration. 
BrAcN(Me)Phe to the enzyme (table 1). However, 
unlike the case of nitro-carboxypeptidase A, glutamic 
acid 270 in the acetyl derivative of the enzyme appears 
to be more reactive toward BrAcN(Me)Phe than in 
the unmodified enzyme (i.e. T is decreased). 
Additionally, at concentrations of BrAcN(Me)Phe 
greater than 10 mM, tl ,2 of acetyl-carboxypeptidase 
A increases as the inhibitor concentration is increased. 
This effect may be due to excess inhibitor protection 
and presumably is analogous to excess substrate inhi- 
bition. Thus, acetylation of carboxypeptidase A may 
generate additional binding sites for BrAcN(Me)Phe 
allowing formation of complexes of enzyme with two 
or more molecules of reagent which diminish the 
reactivity of glutamic acid 270 toward the inhibitor. 
In contrast, acetylation of carooxypeptidase A 
apparently relieves the inherent excess substrate in- 
hibition toward N-blocked dipeptides [9]. 
4. Discussion 
The proposal that tyrosine 248 serves as a proton 
donor in the carboxypeptidase A catalyzed hydrolysis 
of peptide substrates is based in part upon the loss of 
peptidase activity upon acetylation or nitration of the 
enzyme. Conceivably, tyrosine 248 could also func- 
tion by orienting the substrate for nucleophilic attack 
by the y-carboxylate of glutamic acid 270. If the 
latter were the case, the nitro- and acetyl-derivatives 
of carboxypeptidase A would have diminished pep- 
tidase activity due to the inability of the modified 
tyrosine 248 to properly orient the substrate. 
Like peptide substrates, BrAcN(Me)Phe binds at the 
active site of carboxypeptidase A. The inactivation 
of the enzyme by this reagent occurs by alkylation 
of the y-carboxylate of glutamic acid 270. The favorable 
orientation of BrAcN(Me)Phe and glutamic acid 270 
accounts for most of the enhancement in the rate 
of reaction relative to that of model systems [4]. 
If the unmodified form of tyrosine 248 is required 
for the correct orientation of peptide substrates for 
nucleophihc attack by glutamic acid 270, it could be 
expected that a similar requirement would hold for 
the correct orientation of BrAcN(Me)Phe. Since modi- 
fication of tyrosine 248 by acetylation or by nitration 
has relatively little effect on the apparent first order 
rate constant for the reaction with BrAcN(Me)Phe 
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(see table I), it seems likely that tyrosine 248 plays 
no role in the orientation of the affinity label but 
functions primarily in a catalytic rather than a steric 
role in the carboxypeptidase A catalyzed hydrolysis 
of peptide substrates. 
Acknowledgement 161 
This work was supported in part by the National 
Institutes of Health Grant #GM 1573 1. 
121 
131 
[41 
151 
171 
181 
I91 
References 
1101 
[l] Lipscomb, W. M., Hartsuck, J. A., Reeke, Jr., G. N., 
Quiocho, F. A., Bethge, P. H., Ludwig, M. L, Steitz, 
T. A., Muirhead, H. and Coppola, J. C. (1968) Brook- 
haven Symp. Biol. 21, 24. 
1111 
1121 
Petra, P. H. (1971) Biochemistry 10, 3163. 
Petra, P. H. and Neurath, H. (197 1) Biochemistry 10, 
3171. 
Hass, G. M. and Neurath, H. (1971) Biochemistry 10, 
3535. 
Hass, G. M. and Neurath, H. (1971) Biochemistry 10, 
3541. 
Riordan, J. F., Sokolovsky, M. and Vallee, B. L. (1967) 
Biochemistry 6, 358. 
Simpson, R. T., Riordan, J. F. and Vallee, B. J_ (1963) 
Biochemistry 2, 616. 
Petra, P. H. and Neurath, H. (1969) Biochemistry 8, 
2466. 
Whitaker, T. A., Menger, F. and Bender, M. L. (1966) 
Biochemistry 5, 386. 
McClure, W. O., Neurath, H. and Walsh, K. A. (1964) 
Biochemistry 3, 4897. 
Meloche, H. P. (1967) Biochemistry 6, 2273. 
Sokolovsky, M. and Eisenbach, L. (1972) Eur. J. Bio 
them. 25,483. 
165 
